KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Cash from Operations (2020 - 2025)

Aurinia Pharmaceuticals (AUPH) has disclosed Cash from Operations for 6 consecutive years, with 45668000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Operations rose 51.65% year-over-year to 45668000.0, compared with a TTM value of 135658000.0 through Dec 2025, up 205.62%, and an annual FY2025 reading of 135658000.0, up 205.62% over the prior year.
  • Cash from Operations was 45668000.0 for Q4 2025 at Aurinia Pharmaceuticals, up from 44449000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 45668000.0 in Q4 2025 and bottomed at 53541000.0 in Q1 2021.
  • Average Cash from Operations over 5 years is 4531800.0, with a median of 8051500.0 recorded in 2023.
  • The sharpest move saw Cash from Operations tumbled 136.82% in 2021, then surged 660.62% in 2024.
  • Year by year, Cash from Operations stood at 25922000.0 in 2021, then skyrocketed by 140.31% to 10450000.0 in 2022, then surged by 36.96% to 14312000.0 in 2023, then skyrocketed by 110.41% to 30114000.0 in 2024, then soared by 51.65% to 45668000.0 in 2025.
  • Business Quant data shows Cash from Operations for AUPH at 45668000.0 in Q4 2025, 44449000.0 in Q3 2025, and 44241000.0 in Q2 2025.